riboflavin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases pancreatic cancer incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“The risk of pancreatic cancer increased with increasing level of serum riboflavin in a dose-dependent manner, especially in men (Ptrend = 0.003).”
Quoted verbatim from The Association Between Serum Riboflavin and Flavin Mononucleotide With Pancreatic Cancer: Findings From a Prospective Cohort Study.. - Study
- case-control
- Population
- Nested case-control study within the Singapore Chinese Health Study (58 cases, 104 matched controls); exposure is endogenous serum riboflavin concentration across tertiles, not an administered dose
The Association Between Serum Riboflavin and Flavin Mononucleotide With Pancreatic Cancer: Findings From a Prospective Cohort Study.2023PMID:37523604Permalink
Keep reading
- Everything the graph holds on riboflavin
- Every compound studied against Pancreatic cancer incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4Q20GG76TW35NQX2QP6GC32